Nisa Investment Advisors LLC Decreases Stake in Cabot Corporation $CBT

Nisa Investment Advisors LLC lowered its position in Cabot Corporation (NYSE:CBT) by 47.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,216 shares of the specialty chemicals company’s stock after selling 1,101 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Cabot were worth $91,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the company. Leeward Investments LLC MA raised its holdings in Cabot by 12.1% during the second quarter. Leeward Investments LLC MA now owns 203,616 shares of the specialty chemicals company’s stock worth $15,271,000 after purchasing an additional 21,997 shares in the last quarter. State of New Jersey Common Pension Fund D raised its holdings in Cabot by 11.6% during the second quarter. State of New Jersey Common Pension Fund D now owns 25,435 shares of the specialty chemicals company’s stock worth $1,908,000 after purchasing an additional 2,647 shares in the last quarter. First Citizens Bank & Trust Co. raised its holdings in Cabot by 144.4% during the second quarter. First Citizens Bank & Trust Co. now owns 14,352 shares of the specialty chemicals company’s stock worth $1,076,000 after purchasing an additional 8,479 shares in the last quarter. DekaBank Deutsche Girozentrale acquired a new stake in Cabot during the second quarter worth approximately $148,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Cabot during the second quarter worth approximately $1,373,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Stock Down 6.6%

CBT stock opened at $61.56 on Wednesday. The company has a fifty day moving average price of $74.73 and a 200 day moving average price of $75.88. Cabot Corporation has a 12 month low of $61.18 and a 12 month high of $117.46. The company has a market cap of $3.27 billion, a price-to-earnings ratio of 8.05 and a beta of 0.88. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.13 and a quick ratio of 1.41.

Cabot (NYSE:CBT) last released its quarterly earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing the consensus estimate of $1.72 by ($0.02). Cabot had a net margin of 11.14% and a return on equity of 25.68%. The business had revenue of $899.00 million during the quarter, compared to analysts’ expectations of $967.02 million. During the same quarter last year, the company earned $1.80 EPS. The firm’s revenue for the quarter was down 10.2% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Sell-side analysts expect that Cabot Corporation will post 7.57 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. UBS Group set a $82.00 price objective on shares of Cabot and gave the stock a “neutral” rating in a report on Tuesday, August 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Wednesday, October 8th. Finally, Mizuho cut their price objective on shares of Cabot from $90.00 to $88.00 and set an “outperform” rating on the stock in a report on Friday, October 3rd. One equities research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Cabot currently has an average rating of “Hold” and a consensus target price of $85.00.

Insider Buying and Selling

In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the business’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $79.28, for a total value of $9,072,486.08. Following the transaction, the chief executive officer directly owned 361,518 shares of the company’s stock, valued at approximately $28,661,147.04. The trade was a 24.04% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 3.03% of the stock is currently owned by company insiders.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.